Scott C. Kogan

Leukemia initiated by PMLRARalpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable.

J. Bishop, S. Kogan, M. Privalsky, 2000, Blood.

A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657.

M. L. Le Beau, D. Gilliland, T. Abrams, 2003, Blood.